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Background
Gliomas are the most common primary malignant central
nervous system tumors arising from glial cells accounting
for 80% of all malignant brain tumors. Many mutations
occur frequently in genes that control cell cycle and prolif-
eration leading to tumor progression. Major genes that are
associated with the malignant tumors are MGMT, hTERT,
TP53, PTEN, P16. Phosphatase and tensin homologue
deleted on chromosome 10 (PTEN) is a tumor suppressor
gene deleted or mutated in many cancers. It plays a signifi-
cant role in cellular processes like cell cycle progression,
apoptosis, translation, growth, proliferation and migration
by negatively controlling PI3/AKt pathway. Deregulation of
PI3K signaling pathways proceed from genetic alterations
in the PTEN gene on 10q23 at the level of mutation, LOH
and methylation identified in 60% of glioblastoma. Recent
reports show that absence of PTEN was associated with
increased tumor malignancy in gliomas. This seems to
have prognostic significance and accepted as independent
prognostic factor. In this study 15 high grade glioma tissues
were collected from neurosurgery department and con-
firmed as glioma histologically.
Material and methods
DNA was isolated using Qiagen kit and bisulphite DNA
conversion was done by Qiagen Epitect. PCR was per-
formed to check the methylation status in the promoter
region of PTEN gene.
Results
We noticed that around 50% of patients DNA show
methylation in promoter region of PTEN gene when
compared with healthy control DNA. We are looking at
the response of these patients to chemotherapy and
radiotherapy. We are also looking in to changes in the
PI3/AKt signaling pathway.
Conclusions
There is a possibility of correlation between the methy-
lation status and patients survival.
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